Belén Martínez-Gualda

Statistics

Publications

Citations

261

H-Index

Active since

2016

Affiliations

Rega Institute for Medical Research(Current)

KU Leuven

Instituto de Química Médica

Universidad de Alcalá

Stanford University

Belén Martínez-Gualda is an author at Rega Institute for Medical Research specializing in medicinal chemistry, antiviral structure-activity relationships, and molecular virology.

ORCID

Publications per year

2016–2023

Publications

Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies

Marwah Karim, Sirle Saul, Luca Ghita et al. · Antiviral Research · 2022 · 41 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +14

Viral engagement with host receptors blocked by a novel class of tryptophan dendrimers that targets the 5-fold-axis of the enterovirus-A71 capsid

Liang Sun, Hyunwook Lee, Hendrik Jan Thibaut et al. · PLoS Pathogens · 2019 · 34 citations · Full text

Life Sciences, Infectious Diseases, Medicinal Chemistry +17

Structure-activity relationship study of the pyridine moiety of isothiazolo[4,3-b]pyridines as antiviral agents targeting cyclin G-associated kinase

Belén Martínez-Gualda, Szu‐Yuan Pu, Piet Herdewijn et al. · Bioorganic & Medicinal Chemistry · 2019 · 32 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors

Belén Martínez-Gualda, Liang Sun, Olaia Martí‐Marí et al. · Journal of Medicinal Chemistry · 2019 · 27 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Structure-activity relationship studies on a Trp dendrimer with dual activities against HIV and enterovirus A71. Modifications on the amino acid

Belén Martínez-Gualda, Liang Sun, Eva Rivero‐Buceta et al. · Antiviral Research · 2016 · 22 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

1–5 of 12